Wubi News

Pharmacies facing angry patients over Covid jab confusion

2025-10-07 08:00:04
(File photo)

Pharmacists in England say they are facing "major issues" with large numbers of patients booking appointments for Covid jabs only to find they are no longer eligible.

The criteria have been tightened this year so that only those aged 75 and older are being offered free boosters, along with younger patients who have a weakened immune system.

Between a third and a half of people who turn up for their appointment are having to be turned away at many sites, according to Community Pharmacy England (CPE), which represents more than 10,000 chemists including many major chains.

It has described the situation as "unacceptable" with reports of angry, frustrated patients and abuse aimed at staff.

Paul Williamson, 71, says he was disappointed to find out he was no longer eligible for the Covid vaccine

The changes to eligibility were made on the advice of a group of independent experts called the Joint Committee on Vaccination and Immunisation (JCVI).

It recommended that eligibility for the Covid autumn booster should be changed from 2025.

Last year the jab was offered for free to anyone 65 years old and over and those with a long list of chronic or long-term conditions.

That's now been changed with the age limit raised to all those who turn 75 before January 2026, plus residents in care homes for older adults and people classed as immunosuppressed.

That includes those undergoing some cancer treatment and transplant patients, along with those living with HIV and some genetic disorders.

But it means many people with conditions such as diabetes, heart disease, respiratory illneses, asthma and severe mental illness will no longer qualify.

In addition, pregnant women and frontline health and social care workers will not be offered the jab for free this autumn.

The JCVI said Covid was now a "relatively mild disease for most people", with rates of hospitalisation and death having "reduced significantly".

It said focusing on the oldest adults and individuals whose immune systems are compromised, as the two groups who continue to be at higher risk, was based on "a standard cost-effectiveness assessment, in line with other routine vaccinations".

Additional reporting by Alex Emery and Elena Bailey.

Get our flagship newsletter with all the headlines you need to start the day. Sign up here.